Informations générales (source: ClinicalTrials.gov)
Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Observational
GERCOR - Multidisciplinary Oncology Cooperative Group (Voir sur ClinicalTrials)
mai 2022
juin 2040
02 mai 2026
The objective of this study is to identify prognosis and predictive markers of response
to treatments (surgery, chemotherapy, targeted therapy,loco-regional treatments ) in
patients with bile duct cancer. The effectiveness and tolerance of these treatments in
current practice will also be evaluated.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Antoine HOLLEBECQUE | 31/05/2024 11:15:30 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Avicenne | Jean Charles NAULT, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Cochin | Romain CORIAT, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Saint Antoine | Raphaël COLLE, MD | Contact (sur clinicalTrials) | |||
| IFSI DU GROUPE HOSP. PITIÉ SALPÉTRIÈRE | Jean Baptiste BACHET, MD | Contact (sur clinicalTrials) | |||
| INSTITUT GUSTAVE ROUSSY | Antoine HOLLEBECQUE, MD | Contact (sur clinicalTrials) | |||
| INSTITUT MUTUALISTE MONTSOURIS | Christophe LOUVET, MD | Contact (sur clinicalTrials) | |||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Eugène Marquis - Rennes - France | Julien EDELINE, MD | Contact (sur clinicalTrials) | |||
| Centre Léon Bérard - Lyon - France | Mathieu SARABI, MD | Contact (sur clinicalTrials) | |||
| CHR Orléans - Orléans - France | Jean Paul LAGASSE, MD | Contact (sur clinicalTrials) | |||
| CHRU Nancy Site Brabois - Vandœuvre-lès-Nancy - France | Marie MULLER, MD | Contact (sur clinicalTrials) | |||
| CHU Besançon - Besançon - France | Angélique VIENOT, MD | Contact (sur clinicalTrials) | |||
| CHU Poitiers - Potiers - France | David TOUGERON, MD | Contact (sur clinicalTrials) | |||
| CHU Rouen Charles Nicolle - Rouen - France | Lilian SCHWARZ, MD | Contact (sur clinicalTrials) | |||
| CHU Saint Eloi Montpellier - Montpellier - France | Eric ASSENAT, MD | Contact (sur clinicalTrials) | |||
| Hôpital Robert Debré -CHU Reims - Reims - France | Alexandra HEURGUE, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHU - Henri Mondor - Créteil - France | Christophe TOURNIGAND, MD | Contact (sur clinicalTrials) | |||
| CHU Angers - Angers - France | Carole VITELLIUS, MD | Contact (sur clinicalTrials) | |||
| CHU Dijon - Dijon - France | Sylvain MANFREDI, MD | Contact (sur clinicalTrials) | |||
| CHU Grenoble - Grenoble - France | Gaël ROTH, MD | Contact (sur clinicalTrials) | |||
| CHU Hôpital Sud Amiens - Amiens - France | Vincent HAUTEFEUILLE, MD | Contact (sur clinicalTrials) | |||
| CHU Lille - Lille - France | Anthony TURPIN, MD | Contact (sur clinicalTrials) | |||
| CHU Rangueil - Toulouse - France | Nadim FARES, MD | Contact (sur clinicalTrials) | |||
| CHU Saint Etienne - Saint-Etienne - France | Nicolas WILLET, MD | Contact (sur clinicalTrials) | |||
| CHU Tours - Tours - France | Thierry LECOMTE, MD | Contact (sur clinicalTrials) | |||
| Hôpital Ambroise Paré - Paris - France | Aude GUILLEMIN, MD | Contact (sur clinicalTrials) | |||
| Hôpital Croix Rousse - Lyon - France | Marielle GUILLET, MD | Contact (sur clinicalTrials) | |||
| Hôpital Edouard Herriot - Lyon - France | Thomas WALTER, MD | Contact (sur clinicalTrials) | |||
| Hôpital Haut Lévêque - Pessac - France | Jean François BLANC, MD | Contact (sur clinicalTrials) | |||
| Hôpital Privé Jean Mermoz - Lyon - France | Pascal ARTRU, MD | Contact (sur clinicalTrials) | |||
| Hôpital Saint Louis - Paris - France | Nelson LOURENCO, MD | Contact (sur clinicalTrials) | |||
| Institut Curie - Saint-Cloud - France | Cindy NEUZILLET, MD | Contact (sur clinicalTrials) | |||
| Institut Paoli Calmette - Marseille - France | Brice CHANEZ, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
- All locations of primitives (intrahepatic CCA, extrahepatic CCA, adenocarcinoma of
the gallbladder; ampullomas excluded)
- Age > 18 years
- Diagnosed between 2003 and 2030 (minimum follow-up 2 years)
- Written written non-opposition +/- signed informed consent for genetic studies
(N.B.:
exemption requested for a deceased patient) N.B. Authorized inclusion in a therapeutic
research protocol
Exclusion Criteria:
- Patient under guardianship, curatorship or legal protection
- Pregnant or breastfeeding women
- Any medical, psychological or social situation, which could prevent the compliance
with the protocol according to the investigator's assessment
- Refusal to participate in the study